Product Images Ropinirole
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Ropinirole NDC 0781-5782 by Sandoz Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a medication with the name rOPINIRole, in the form of extended-release tablets. The NOC code associated is 0781-5780-31.*
This is a description of a medication with the NDC code 0781-5782.31, named Ropinirole. It is an extended-release tablet that is designed to be taken orally and is for the treatment of Parkinson's disease, particularly for patients who experience restless movements and muscle stiffness. The tablets are produced by Sandoz Inc., located in Princeton, New Jersey. The revision of this medication was finalised in October 2016.*
This is a medication with the National Drug Code (NDC) 0781-5784-31. It comes in the form of tablets and each tablet contains 6.84 mg of ropinirole hydrochloride. It is an extended-release medication used for treatment under the USP.*
INDC 0781-5786-31 is a prescription drug from SANDOZ available in the form of extended-release tablets. It contains rOPINIRole and comes in a pack size of 30 tablets.*
Each tablet of this medication contains 13.68 mg of ropinirole hydrochloride. The medication is manufactured by Sandaz Private Ltd. and comes in a form of extended-release tablets. The tablets are white, round and biconvex with imprinted code “S 525” on one side. The medication is only available with a prescription and should be kept out of reach of children. There are 30 tablets in a bottle.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.